|
⚲
|
| Keyboard |
| Quartel Adrian W
✚
|
|
|---|---|
| CIK # | 0001910132 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001910132] | |
| 4 | [0001910132] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Quartel Adrian W | |
| Zevra Therapeutics Inc | |
| Acer Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Zevra Therapeutics Inc ZVRA
Restricted Stock Unit · derivative
|
2026-01-30 | Option exercise | 11,333 | $0.00 | |
|
Zevra Therapeutics Inc ZVRA
Common Stock
|
2026-01-30 | Sell | 4,533 | $8.83 | 40,026 |
|
Zevra Therapeutics Inc ZVRA
Common Stock
|
2026-01-30 | Option exercise | 11,333 | ||
|
Zevra Therapeutics Inc ZVRA
Stock Option (right to buy) · derivative
|
2026-01-29 | Grant | 75,000 | $0.00 | |
|
Zevra Therapeutics Inc ZVRA
Restricted Stock Unit · derivative
|
2026-01-29 | Grant | 37,500 | $0.00 | |
|
Zevra Therapeutics Inc ZVRA
Restricted Stock Unit · derivative
|
2025-01-30 | Grant | 34,000 | $0.00 | |
|
Zevra Therapeutics Inc ZVRA
Stock Option (right to buy) · derivative
|
2025-01-30 | Grant | 68,000 | $0.00 | |
|
Acer Therapeutics Inc ACER
Employee Stock Option (right to buy) · derivative
|
2023-03-14 | Grant | 30,000 | $0.00 | |
|
Acer Therapeutics Inc ACER
Employee Stock Option (right to buy) · derivative
|
2022-02-21 | Grant | 200,000 | $0.00 |